Morgan Stanley
ULBI icon

Morgan Stanley’s Ultralife ULBI Stock Holding History

Morgan Stanley’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.2K Sell
5,704
-443
-7% -$2.75K ﹤0.01% 6526
2025
Q4 		$35.2K Sell
6,147
-399
-6% -$2.46K ﹤0.01% 6538
2025
Q3 		$44.6K Sell
6,546
-1,610
-20% -$12.2K ﹤0.01% 6452
2025
Q2 		$73.2K Sell
8,156
-12,040
-60% -$71.4K ﹤0.01% 6230
2025
Q1 		$109K Sell
20,196
-22,640
-53% -$154K ﹤0.01% 5969
2024
Q4 		$319K Buy
42,836
+8,028
+23% +$66K ﹤0.01% 5607
2024
Q3 		$315K Buy
34,808
+12,607
+57% +$130K ﹤0.01% 5586
2024
Q2 		$236K Buy
22,201
+17,415
+364% +$185K ﹤0.01% 5595
2024
Q1 		$42.2K Sell
4,786
-19,614
-80% -$160K ﹤0.01% 6284
2023
Q4 		$166K Buy
24,400
+16,645
+215% +$137K ﹤0.01% 6014
2023
Q3 		$75.7K Sell
7,755
-147,165
-95% -$1.18M ﹤0.01% 6000
2023
Q2 		$750K Sell
154,920
-12,958
-8% -$56.3K ﹤0.01% 5005
2023
Q1 		$675K Sell
167,878
-15,776
-9% -$63.3K ﹤0.01% 5082
2022
Q4 		$709K Sell
183,654
-17,419
-9% -$80.4K ﹤0.01% 5055
2022
Q3 		$968K Buy
201,073
+173,739
+636% +$822K ﹤0.01% 4901
2022
Q2 		$124K Sell
27,334
-96,057
-78% -$473K ﹤0.01% 6161
2022
Q1 		$662K Buy
123,391
+122,245
+10,667% +$655K ﹤0.01% 5234
2021
Q4 		$7K Sell
1,146
-1,455
-56% -$8.94K ﹤0.01% 7579
2021
Q3 		$19K Buy
2,601
+580
+29% +$4.67K ﹤0.01% 7120
2021
Q2 		$17K Buy
2,021
+173
+9% +$1.49K ﹤0.01% 7060
2021
Q1 		$15K Sell
1,848
-19,564
-91% -$139K ﹤0.01% 6825
2020
Q4 		$138K Buy
21,412
+19,623
+1,097% +$124K ﹤0.01% 5779
2020
Q3 		$11K Sell
1,789
-1,843
-51% -$12.1K ﹤0.01% 6252
2020
Q2 		$26K Buy
3,632
+2,807
+340% +$20.5K ﹤0.01% 5936
2020
Q1 		$4K Sell
825
-2,069
-71% -$14.2K ﹤0.01% 6281
2019
Q4 		$21K Buy
2,894
+570
+25% +$4.73K ﹤0.01% 6098
2019
Q3 		$20K Sell
2,324
-6,038
-72% -$51.7K ﹤0.01% 6019
2019
Q2 		$67K Sell
8,362
-569
-6% -$5.18K ﹤0.01% 5494
2019
Q1 		$92K Sell
8,931
-1,534
-15% -$13.8K ﹤0.01% 5424
2018
Q4 		$70K Buy
10,465
+126
+1% +$916 ﹤0.01% 5665
2018
Q3 		$85K Buy
10,339
+401
+4% +$3.75K ﹤0.01% 5737
2018
Q2 		$95K Buy
9,938
+1,221
+14% +$11.7K ﹤0.01% 5758
2018
Q1 		$87K Sell
8,717
-1,900
-18% -$14.7K ﹤0.01% 5746
2017
Q4 		$69K Sell
10,617
-1,069
-9% -$7.17K ﹤0.01% 5741
2017
Q3 		$79K Buy
11,686
+164
+1% +$1.12K ﹤0.01% 5639
2017
Q2 		$82K Buy
11,522
+3,641
+46% +$22.3K ﹤0.01% 5709
2017
Q1 		$43K Buy
7,881
+6,638
+534% +$36.1K ﹤0.01% 5877
2016
Q4 		$6K Hold
1,243
– – ﹤0.01% 6255
2016
Q3 		$5K Sell
1,243
-400
-24% -$1.76K ﹤0.01% 6241
2016
Q2 		$8K Sell
1,643
-223
-12% -$1.06K ﹤0.01% 6112
2016
Q1 		$9K Sell
1,866
-1,460
-44% -$7.91K ﹤0.01% 6158
2015
Q4 		$22K Buy
3,326
+2,826
+565% +$18.7K ﹤0.01% 6004
2015
Q3 		$3K Sell
500
-30
-6% -$134 ﹤0.01% 6455
2015
Q2 		$2K Buy
530
+1
+0.2% +$4 ﹤0.01% 6518
2015
Q1 		$2K Hold
529
– – ﹤0.01% 6436
2014
Q4 		$2K Sell
529
-1
-0.2% -$3 ﹤0.01% 6440
2014
Q3 		$2K Buy
530
+1
+0.2% +$3 ﹤0.01% 6448
2014
Q2 		$2K Sell
529
-1
-0.2% -$4 ﹤0.01% 6393
2014
Q1 		$2K Buy
530
+30
+6% +$115 ﹤0.01% 6352
2013
Q4 		$2K Buy
+500
New +$1.87K ﹤0.01% 6261

Other funds holding ULBI

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
THC
Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Morgan Stanley's ULBI Position: Q1 2026 in Review

Morgan Stanley reduced its Ultralife (ULBI) stake by 7.2% in Q1 2026, selling an estimated $2.75K and leaving 5,704 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6526.

Morgan Stanley first reported a position in ULBI in Q4 2013 and has held it in 50 quarters since. The position peaked at $968K in Q3 2022. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • Morgan Stanley held 5,704 shares of Ultralife worth $37.2K as of Q1 2026.
  • Morgan Stanley sold 443 Ultralife shares in Q1 2026, an estimated $2.75K.
  • Ultralife made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6526 holding.
  • Morgan Stanley first reported a position in Ultralife in Q4 2013 and has held it in 50 quarters since.
  • Morgan Stanley's Ultralife position peaked at $968K in Q3 2022.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.